Table 1.
Patients with CD | ||||
---|---|---|---|---|
Disease activity | Active (onset) | Inactive | Non‐CD ileitis | Controls |
Number | 25 | 10 | 8 | 15 |
Age (range), years | 31·1 ± 14·1 (18–74) | 32·4 ± 9·4 (21–46) | 27·4 ± 13·7 (18–57) | 37·6 ± 12·3 (27–67) |
Sex (M/F) | 15/10 | 5/5 | 4/4 | 7/8 |
Disease location, n | ||||
L1 Ileal | 5 | 3 | Terminal ileum | – |
L3 Ileocolonic | 10 | 7 | – | |
L2 Colonic | 10 | – | – | |
Disease behaviour, n | ||||
B1 Inflammatory | 24 | 7 | – | – |
B2 Stricturing | 1 | 2 | – | – |
B3 Penetrating | 0 | 1 | – | – |
P Peri‐anal disease | 9 | 3 | – | – |
Harvey–Bradshaw Index | 8 | 3 | ||
Concomitant treatment, n | ||||
5‐Aminosalicylates | – | 1 | – | – |
Thiopurines | – | 4 | – | – |
Anti‐TNF‐α | – | 2 | – | – |
Double IS | – | 1 | – | – |
None | – | 2 | – | – |
Mean ± standard deviation (s.d.). CD = Crohn's disease; IS = immunosuppression; TNF = tumour necrosis factor; M/F = male/female.